Aktie A2P91H BETA DRUGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Beta Drugs Limited

Aktien

A2P91H

INE351Y01019

BETA

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 13:43:51 06.05.2024 		% 5 Tage % 1. Jan.
1’300 INR -3.53% Intraday Chart für Beta Drugs Limited 0.00% -11.56%
2023 Beta Drugs Limited berichtet über die Ergebnisse für das Halbjahr bis zum 30. September 2023 CI
2023 Beta Drugs Limited meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2022
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Beta Drugs Limited Gets DCGI Approval for Its New Drug KABONIB
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2021
Beta Drugs Ltd Receives WHO- GMP Approval for Its API Plant
Beta Drugs Limited Announces Demise of Vijvay Kumar Batra, Managing Director and Announces Executive Promotions
Beta Drugs Limited Announces Demise of Vijvay Kumar Batra, Board Chairman; Promotes Rahul Batra to the Board Chairman
Beta Drugs Limited Appoints Mr. Varun Batra as Joint Managing Director of the Company
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2020
1,732,000 Equity Shares of Beta Drugs Limited are subject to a Lock-Up Agreement Ending on 15-OCT-2020.
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2020
Beta Drugs Ltd. Receives Registration Certificates for 20 Injectables from Ministry of Health Uzbekistan
Beta Drugs Limited acquired Adley Lab Ltd from group of shareholders for INR 45 million.
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2019
Beta Drugs Limited agreed to acquire Adley Lab Ltd from a group of shareholders for INR 45.04 million
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2019
4,621,500 Equity Shares of Beta Drugs Limited are subject to a Lock-Up Agreement Ending on 15-OCT-2018.
Beta Drugs Limited has completed an IPO in the amount of INR 195.16 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P91H Aktie
  4. Nachrichten Beta Drugs Limited
  5. Andere Sprachen